Publicaciones de Juan José Gagliardino

2019

  • Effects of islet neogenesis associated protein depend on vascular endothelial growth factor gene expression modulated by hypoxia-inducible factor 1-alpha. Román CL, Maiztegui B, Mencucci MV, Ahrtz L, Algañarás M, Del Zotto H, Gagliardino JJ, Flores LE. Peptides. 2019 Jul;117:170090. doi: 10.1016/j.peptides.2019.05.002. Epub 2019 May 20.
  • Treat-to-target HbA1c and lipid profile to prolong beta-cell mass/function and optimize treatment goal attainment. Gagliardino, J.J., Elgart, J., Forti, L., Guaita, M.S., Chantelot, J.M.(2019) Diabetes/Metabolism Research and Reviews, 35 (6), art. no. e3166,DOI: 10.1002/dmrr.3166
  • Diabetes management and treatment approaches outside of North America and West Europe in 2006 and 2015. Tabesh, M., Magliano, D.J., Tanamas, S.K., Surmont, F., Bahendeka, S., Chiang, C.-E., Elgart, J.F., Gagliardino, J.J., Kalra, S., Krishnamoorthy, S., Luk, A., Maegawa, H., Motala, A.A., Pirie, F., Ramachandran, A., Tayeb, K., Vikulova, O., Wong, J., Shaw, J.E. (2019) Acta Diabetologica, 56 (8), pp. 889-897. DOI: 10.1007/s00592-018-01284-4
  • Type 2 diabetes: Prescription patterns and treatment outcomes of IDMPS survey in Argentina. Gagliardino, J.J., Elgart, J., Forti, L., Ivanna, Q., Chantelot, J.M.(2019) Diabetes Research and Clinical Practice, 153, pp. 86-92. DOI: 10.1016/j.diabres.2019.05.008
  • Cardiovascular disease management in people with diabetes outside North America and Western Europe in 2006 and 2015. Tabesh, M., Magliano, D.J., Tanamas, S.K., Surmont, F., Bahendeka, S., Chiang, C.-E., Elgart, J.F., Gagliardino, J.J., Kalra, S., Krishnamoorthy, S., Luk, A., Maegawa, H., Motala, A.A., Pirie, F., Ramachandran, A., Tayeb, K., Vikulova, O., Wong, J., Shaw, J.E. (2019) Diabetic Medicine, 36 (7), pp. 878-887. DOI: 10.1111/dme.13858
  • Drug treatment of type 2 diabetes: Its cost is significantly associated with HbA1c levels. Elgart, J.F., Silvestrini, C., Prestes, M., Gonzalez, L., Rucci, E., Gagliardino, J.J. (2019) International Journal of Clinical Practice, 73 (4), art. no. e13336. DOI: 10.1111/ijcp.13336
  • Dyslipidemia: The untreated metabolic dysfunction in people with type 2 diabetes in Latin America. ARETAEUS study outcomes. Gagliardino, J.J., Arechavaleta, R., Goldberg Eliaschewitz, F., Iglay, K., Brodovicz, K., Gonzalez, C.D., Yu, S., Ravi Shankar, R., Heisel, O., Keown, P., Tunceli, K. (2019) Journal of Clinical and Translational Endocrinology, 15, pp. 76-80. DOI: 10.1016/j.jcte.2019.01.002
  • Increasing DNA isolation performance from blood cells using a modified commercial low-cost reagent. Kraemer, M.N., Mencucci, M.V., Abba, M., Lacunza, E., Gagliardino, J.J.(2019) Clinical Laboratory, 65 (11), pp. 2179-2183. DOI: 10.7754/Clin.Lab.2019.190349
  • Impact of diabetes education and self-management on the quality of care for people with type 1 diabetes mellitus in the Middle East (the International Diabetes Mellitus Practices Study, IDMPS). Gagliardino, J.J., Chantelot, J.-M., Domenger, C., Ramachandran, A., Kaddaha, G., Mbanya, J.C., Shestakova, M., Chan, J., on behalf of the IDMPS Steering Committee. (2019) Diabetes Research and Clinical Practice, 147, pp. 29-36. DOI: 10.1016/j.diabres.2018.09.008
  • Diabetes education and health insurance: How they affect the quality of care provided to people with type 1 diabetes in Latin America. Data from the International Diabetes Mellitus Practices Study (IDMPS). Gagliardino, J.J., Chantelot, J.-M., Domenger, C., Ilkova, H., Ramachandran, A., Kaddaha, G., Claude Mbanya, J., Chan, J., Aschner, P., on behalf of the IDMPS Steering Committee. (2019) Diabetes Research and Clinical Practice, 147, pp. 47-54. DOI: 10.1016/j.diabres.2018.08.007

2018

  • Diabetes primary prevention program: New insights from data analysis of recruitment period. Gagliardino JJ, Elgart JF, Bourgeois M, Etchegoyen G, Fantuzzi G, Ré M, Ricart JP, García S, Giampieri C, González L, Suárez-Crivaro F, Kronsbein P, Angelini JM, Martínez C, Martínez J, Ricart A, Spinedi E. Diabetes Metab Res Rev. 2018 Jan;34. doi: 10.1002/dmrr.2943. Epub
  • Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis. Lim LL, Lau ESH, Kong APS, Davies MJ, Levitt NS, Eliasson B, Aguilar-Salinas CA, Ning G, Seino Y, So WY, McGill M, Ogle GD, Orchard TJ, Clarke P, Holman RR, Gregg EW, Gagliardino JJ, Chan JCN. Diabetes Care. 2018;41:1312-1320. Review.
  • INGAP-PP effects on beta-cell mass and function are related to its positive effect on islet angiogenesis and VEGFA production. Román CL, Maiztegui B, Del Zotto H, Gagliardino JJ, Flores LE. Mol Cell Endocrinol. 2018 Jul 15;470:269-280.
  • Microbiota y eje entero insular. Saad M, Gagliardino JJ. Incretinas. Diabetes Mellitus tipo 2: Abordaje multifactorial y el rol de las incretinas en su fisiopatología y tratamiento. Segunda Edición. 29-39
  • El Glucagón y su Regulación en la Fisiopatología de la DMT2. Gagliardino JJ, Flores LE, Maiztegui B, Román CL. Incretinas. Diabetes Mellitus tipo 2: Abordaje multifactorial y el rol de las incretinas en su fisiopatología y tratamiento. Segunda Edición. 41-52
  • Diabetes tipo 2: patrones prescriptivos y resultados del tratamiento en IDMPS (International diabetes management practices study) en Argentina. Gagliardino JJ, Elgart JF, Forti L, Querzoli I, De Luca J, Chatelau J. XXI Congreso Argentino de Diabetes, Sociedad Argentina de Diabetes (SAD). Revista de la SAD. 2018; 52:81.
  • Tratamiento farmacológico de la diabetes tipo 2: su costo está significativamente asociado con los niveles de HbA1c. Elgart JF, Silvestrini C, Prestes M, Gonzalez L, Rucci E, Gagliardino JJ. XXI Congreso Argentino de Diabetes, Sociedad Argentina de Diabetes (SAD). Revista de la SAD. 2018; 52:95-96.
  • Aparición cronológica de las alteraciones endocrino-metabólicas inducidas por una dieta rica en fructosa. Román LC, Maiztegui B, Flores LE, Mencucci MV, Villagarcía HG, Castro MC, Massa ML, Gagliardino JJ, Francini F. XXI Congreso Argentino de Diabetes. Revista de la Sociedad Argentina de Diabetes 52: 52, 2018
  • Metabolismo hepático de carbohidratos: un nuevo blanco del pentadecapéptido asociado a la neogénesis insular. Villagarcía HG, Román C, Castro MC, González Arbeláez L, Ronco MT, Francés DE, Massa ML, Maiztegui B, Flores LE, Gagliardino JJ, Francini F. XXI Congreso Argentino de Diabetes. Revista de la Sociedad Argentina de Diabetes 52: 52, 2018
  • ANGIOGÉNESIS INSULAR: SU ROL EN EL AUMENTO DE LA MASA Y FUNCIÓN DE CÉLULAS ß INDUCIDO POR INGAP-PP. Román Carolina Lisi, Maiztegui Bárbara, Del Zotto Héctor, Mencucci María victoria, Gagliardino Juan José, Flores Luis Emilio. XXI Congreso Argentino de Diabetes. Revista de la Sociedad Argentina de Diabetes 52: 52, 2018
  • Ingesta alimentaria en la población adulta de dos ciudades de la Provincia de Buenos Aires: su adecuación a las recomendaciones nutricionales. García S, Fantuzzi G, Angelini JM, Bourgeois M, Elgart JF, Etchegoyen G, Giampieri C, González L, Kronsbein P, Martínez C, Martínez J, Prestes M, Ré M, Ricart A, Ricart JP, Gagliardino JJ. Actualización en Nutrición. 2018 Jun; 19(2): 38-43. (ISSN 1667-8052).
  • Impaired endocrine-metabolic homeostasis: underlying mechanism of its induction by unbalanced diet. Maiztegui B, Román CL, Gagliardino JJ, Flores LE. Clin Sci (Lond). 2018;132:869-881
  • Liver carbohydrates metabolism: A new islet-neogenesis associated protein peptide (INGAP-PP) target. Villagarcía HG, Román CL, Castro MC, González LA, Ronco MT, Francés DE, Massa ML, Maiztegui B, Flores LE, Gagliardino JJ, Francini F. Peptides. 2018 Mar;101:44-50. doi: 10.1016/j.peptides.2018.01.001. Epub 2018 Jan 3.